Skip to main content
SpringerLink
Log in

The Role of Nonspecific Immunotherapy in the Treatment of Breast Cancer

  • Chapter
Breast Cancer

  • 55 Accesses

Abstract

Although many oncologists and immunologists at present consider the study and manipulation of specific immunity to be primordial, we have devoted most of our efforts over the past 8 years to nonspecific im-munostimulation in cancer patients for the following reasons.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BLOMGREN, H., GLAS, U., FRANZEN, S., GRANBERG, P.O.: Lymphoid cells in carcinoma of the breast. Failure of response to phytohaemaggluti-nin in vitro. Acta radiol. (Stockh.) 12, 434–441 (1973).

    CAS  Google Scholar 

  2. DIMITROV, N.V., ISRAEL, L., PELTIER, A.: Immunological monitoring of cancer patients during treatment with corynebacterium parvum. Proc. Amer. Ass. Cancer Res. and ASCO 16, 258 (1975).

    Google Scholar 

  3. FISHER, B., SAFFER, E., FISHER, E.: Studies concerning the regional lymph node in cancer. Cancer (Philad.) 30, 1202–1215 (1972).

    Article  CAS  Google Scholar 

  4. FISHER, B., WOLMARK, N., SAFFER, E., FISHER, E.: Inhibitory effect of prolonged corynebacterium parvum and cyclophosphamide administration on the growth of established tumors. Cancer (Philad.) 35, 134–143 (1974).

    Article  Google Scholar 

  5. FISHER, B., CARBONE, P., ECONOMOU, S.G., FRELICK, R., GLASS, A., LERNER, H., REDMOND, C., ZELEN, M., BAND, P., KATRYCH, D.L., WOLMARK, N., FISHER, E.: L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. New Engl. J. Med. 292, 117–122 (1975).

    Article  PubMed  CAS  Google Scholar 

  6. HOGE, A.F., HARTSUCK, J.M., KOLLMORGEN, G.M., SCHILLING, J.A.: Endocrine and immunologic studies in breast cancer. Amer. J. Surg. 126, 722–728 (1973).

    Article  PubMed  CAS  Google Scholar 

  7. ISRAEL, L., HALPERN, B.: Le corynebacterium parvum dans les cancers avancés. Nouv. Presse med. 1, 19–23 (1972).

    PubMed  CAS  Google Scholar 

  8. ISRAEL, L.: Preliminary results of non-specific immunotherapy for lung cancer. Cancer Chemother. Rep. 4. (Part 3), 283–286 (1973).

    CAS  Google Scholar 

  9. ISRAEL, L.: A randomized study of chemotherapy versus chemotherapy and immune therapy with corynebacerium parvum in advanced breast cancer. In: Conferences, Symposium, Workshops of the Xlth International Cancer Congress, Florence. MILANO, A. (ed.). 1914a, Vol. I, pp. 222–223.

    Google Scholar 

  10. ISRAEL, L.: Nonspecific immunostimulation in bronchogenic cancer. Scand. J. resp. Dis. Suppl. 89, 95–105 (1974).

    CAS  Google Scholar 

  11. ISRAEL, L., EDELSTEIN, R., DEPIERRE, A., DIMITROV, N.: Brief communication: Daily intravenous infusions of corynebacterium parvum in twenty patients with disseminated cancer: A preliminary report of clinical and biologic findings. J. Nat. Cancer Inst. 55, 29–33 (1975).

    PubMed  CAS  Google Scholar 

  12. LIKHITE, V.V.: Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum. J. Immunol. 114, 1736–1742 (1975).

    PubMed  CAS  Google Scholar 

  13. MITCHEL, R.J.: The delayed hypersensitivity response in primary breast carcinoma as an index of host restistance. Brit. J. Surg. 59, 505–508 (1972).

    Article  Google Scholar 

  14. ROBERTS, M.M., JONES-WILLIAMS, W.: The delayed hypersensitivity reaction in breast cancer. Brit. J. Surg. 61, 549–552 (1974).

    Article  PubMed  CAS  Google Scholar 

  15. WHITAKER, M.D., REES, K., CLARK, G.C.: Reduced lymphocyte transformation in breast cancer. Lancet 1, 892–893 (1971).

    Article  Google Scholar 

  16. WOLMARK, N., FISHER, B.: The effect of a single and repeated administration of corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice. Cancer Res. 34, 2869–2872 (1974).

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. L. Israel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut d’hématologie-oncologie de Montréal, 5400 ouest, boulevard Gouin, Montréal, Québec, H4J 1C5, Canada

    Guy St-Arneault

  2. The University of Alberta, Clinical Sciences Building, Edmonton, Alberta, T6G 2G3, Canada

    Pierre Band

  3. Centre Hospitalier Universitaire, Lariboisière, Paris, France

    Lucien Israël M. D. (Professor de Médecine) (Professor de Médecine)

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Israel, L. (1976). The Role of Nonspecific Immunotherapy in the Treatment of Breast Cancer. In: St-Arneault, G., Band, P., Israël, L. (eds) Breast Cancer. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 57. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81043-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81043-5_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81045-9

  • Online ISBN: 978-3-642-81043-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation